Weighted Average Number of Shares Outstanding, Basic of Outlook Therapeutics, Inc. from 31 Mar 2016 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Outlook Therapeutics, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Mar 2016 to 31 Dec 2025.
  • Outlook Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 60,205,035, a 148% increase year-over-year.
  • Outlook Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2025 was 34,796,120, a 88% increase from 2024.
  • Outlook Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 18,548,813, a 48% increase from 2023.
  • Outlook Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 12,508,817, a 94% decline from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Outlook Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 60,205,035 +35,971,078 +148% 01 Oct 2025 31 Dec 2025 10-Q 17 Feb 2026 2026 Q1
Q3 2025 34,796,120 +16,247,307 +88% 01 Jul 2025 30 Sep 2025 10-K 19 Dec 2025 2025 FY
Q2 2025 36,956,582 +13,729,513 +59% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q3
Q1 2025 30,874,396 +16,604,107 +116% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q2
Q4 2024 24,233,957 +11,221,124 +86% 01 Oct 2024 31 Dec 2024 10-Q 17 Feb 2026 2026 Q1
Q3 2024 18,548,813 +6,039,996 +48% 01 Jul 2024 30 Sep 2024 10-K 19 Dec 2025 2025 FY
Q2 2024 23,227,069 +10,382,990 +81% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q3
Q1 2024 14,270,289 +1,436,959 +11% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q2
Q4 2023 13,012,833 -214,397,700 -94% 01 Oct 2023 31 Dec 2023 10-Q 14 Feb 2025 2025 Q1
Q3 2023 12,508,817 -199,570,655 -94% 01 Jul 2023 30 Sep 2023 10-K 27 Dec 2024 2024 FY
Q2 2023 12,844,079 -207,653,747 -94% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q3
Q1 2023 12,833,330 -206,234,570 -94% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q2
Q4 2022 227,410,533 +39,252,612 +21% 01 Oct 2022 31 Dec 2022 10-Q 14 Feb 2024 2024 Q1
Q3 2022 212,079,472 +59,403,327 +39% 01 Jul 2022 30 Sep 2022 10-K 22 Dec 2023 2023 FY
Q2 2022 220,497,826 +52,077,151 +31% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q3
Q1 2022 219,067,900 +68,337,709 +45% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q2
Q4 2021 188,157,921 +66,408,366 +55% 01 Oct 2021 31 Dec 2021 10-Q 14 Feb 2023 2023 Q1
Q3 2021 152,676,145 01 Jul 2021 30 Sep 2021 10-K 29 Dec 2022 2022 FY
Q2 2021 168,420,675 +77,662,850 +86% 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022 2022 Q3
Q1 2021 150,730,191 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022 2022 Q2
Q4 2020 121,749,555 01 Oct 2020 31 Dec 2020 10-Q 14 Feb 2022 2022 Q1
Q2 2020 90,757,825 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021 2021 Q3
Q2 2018 34,540,056 +10,098,000 +41% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2018 2018 Q3
Q1 2018 25,733,467 +2,009,916 +8.5% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2018 2018 Q2
Q2 2017 24,442,056 +5,625,348 +30% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018 2018 Q3
Q1 2017 23,723,551 +9,568,470 +68% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q2
Q2 2016 18,816,708 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017 2017 Q3
Q1 2016 14,155,081 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q2

Outlook Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 34,796,120 +16,247,307 +88% 01 Oct 2024 30 Sep 2025 10-K 19 Dec 2025 2025 FY
2024 18,548,813 +6,039,996 +48% 01 Oct 2023 30 Sep 2024 10-K 19 Dec 2025 2025 FY
2023 12,508,817 -199,570,655 -94% 01 Oct 2022 30 Sep 2023 10-K 27 Dec 2024 2024 FY
2022 212,079,472 +59,403,327 +39% 01 Oct 2021 30 Sep 2022 10-K 22 Dec 2023 2023 FY
2021 152,676,145 +80,120,509 +110% 01 Oct 2020 30 Sep 2021 10-K 29 Dec 2022 2022 FY
2020 72,555,636 01 Oct 2019 30 Sep 2020 10-K 23 Dec 2021 2021 FY
2018 39,457,664 +15,435,293 +64% 01 Oct 2017 30 Sep 2018 10-K 18 Dec 2018 2018 FY
2017 24,022,371 +6,809,388 +40% 01 Oct 2016 30 Sep 2017 10-K 18 Dec 2018 2018 FY
2016 17,212,983 01 Oct 2015 30 Sep 2016 10-K 29 Dec 2017 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.